C. Franceingelheim, M. Glaxosmithkline, . Sharp, . Dohme, . Merck et al., Maja Mockenhaupt received the Else Kröner Memorial Stipendium for support of clinical research through Else Kröner-Fresenius-Foundation, The Centre National de Génotypage (CNG)

J. Lazarou, B. Pomeranz, and P. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients, JAMA, vol.279, issue.15, pp.2791200-1205, 1998.
DOI : 10.1001/jama.279.15.1200

C. Svensson, E. Cowen, and A. Gaspari, Cutaneous drug reactions, Pharmacol Rev, vol.53, issue.3, pp.357-379, 2001.

S. Wolverton, Update on cutaneous drug reactions, Adv Dermatol, vol.13, pp.65-84, 1997.

J. Roujeau and R. Stern, Severe Adverse Cutaneous Reactions to Drugs, New England Journal of Medicine, vol.331, issue.19, pp.1272-1285, 1994.
DOI : 10.1056/NEJM199411103311906

A. Auquier-dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schroder et al., Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.138, issue.8, pp.1381019-1024, 2002.
DOI : 10.1001/archderm.138.8.1019

B. Rzany, M. Mockenhaupt, S. Baur, W. Schroder, U. Stocker et al., Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990???1992): Structure and results of a population-based registry, Journal of Clinical Epidemiology, vol.49, issue.7, pp.49769-773, 1996.
DOI : 10.1016/0895-4356(96)00035-2

S. Halevy, P. Ghislain, M. Mockenhaupt, J. Fagot, B. Bavinck et al., Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel, Journal of the American Academy of Dermatology, vol.58, issue.1, pp.25-32, 2008.
DOI : 10.1016/j.jaad.2007.08.036

M. Mockenhaupt, C. Viboud, A. Dunant, L. Naldi, S. Halevy et al., Stevens???Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study, Journal of Investigative Dermatology, vol.128, issue.1, pp.35-44, 2008.
DOI : 10.1038/sj.jid.5701033

M. Pirmohamed and B. Park, Genetic susceptibility to adverse drug reactions, Trends in Pharmacological Sciences, vol.22, issue.6, pp.298-305, 2001.
DOI : 10.1016/S0165-6147(00)01717-X

R. Melsom, Familial hypersensitivity to allopurinol with subsequent desensitization, Rheumatology, vol.38, issue.12, p.1301
DOI : 10.1093/rheumatology/38.12.1301

R. Pellicano, A. Silvestris, M. Iannantuono, G. Ciavarella, and M. Lomuto, Familial occurrence of fixed drug eruptions, Acta Derm Venereol, vol.72, issue.4, pp.292-293, 1992.

J. Roujeau, T. Huynh, C. Bracq, J. Guillaume, J. Revuz et al., Genetic Susceptibility to Toxic Epidermal Necrolysis, Archives of Dermatology, vol.123, issue.9, pp.1171-1173, 1987.
DOI : 10.1001/archderm.1987.01660330082014

J. Roujeau, C. Bracq, N. Huyn, E. Chaussalet, C. Raffin et al., HLA phenotypes and bullous cutaneous reactions to drugs, Tissue Antigens, vol.303, issue.Suppl 68, pp.251-254, 1986.
DOI : 10.1111/j.1399-0039.1986.tb00491.x

W. Chung, S. Hung, H. Hong, M. Hsih, L. Yang et al., Medical genetics: A marker for Stevens???Johnson syndrome, Nature, vol.428, issue.6982, p.428486, 2004.
DOI : 10.1038/428486a

S. Hung, W. Chung, L. Liou, C. Chu, M. Lin et al., HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol, Proceedings of the National Academy of Sciences, vol.102, issue.11, pp.1024134-4139, 2005.
DOI : 10.1073/pnas.0409500102

C. Lonjou, N. Borot, P. Sekula, N. Ledger, L. Thomas et al., A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs, Pharmacogenetics and Genomics, vol.18, issue.2, pp.99-107, 2008.
DOI : 10.1097/FPC.0b013e3282f3ef9c

C. Lonjou, L. Thomas, N. Borot, N. Ledger, C. De-toma et al., A marker for Stevens-Johnson syndrome ???: ethnicity matters, The Pharmacogenomics Journal, vol.102, issue.4, pp.265-268, 2006.
DOI : 10.1038/sj.tpj.6500356

M. Pirmohamed, J. Arbuckle, C. Bowman, M. Brunner, D. Burns et al., Investigation into the multidimensional genetic basis of drug-induced Stevens???Johnson syndrome and toxic epidermal necrolysis, Pharmacogenomics, vol.8, issue.12, pp.1661-1691, 2007.
DOI : 10.2217/14622416.8.12.1661

J. Miller, Of race, ethnicity, and rash: the genetics of antiepileptic druginduced skin reactions, Epilepsy Curr, vol.8, issue.5, pp.120-121, 2008.

R. Abe, Toxic epidermal necrolysis and Stevens???Johnson syndrome: Soluble Fas ligand involvement in the pathomechanisms of these diseases, Journal of Dermatological Science, vol.52, issue.3, pp.151-159, 2008.
DOI : 10.1016/j.jdermsci.2008.06.003

M. Pirmohamed, Genetic factors in the predisposition to drug-induced hypersensitivity reactions, The AAPS Journal, vol.8, issue.1, pp.20-26, 2006.
DOI : 10.1208/aapsj080103

S. Heath, I. Gut, P. Brennan, J. Mckay, V. Bencko et al., Investigation of the fine structure of European populations with applications to disease association studies, European Journal of Human Genetics, vol.28, issue.12, pp.161413-1429, 2008.
DOI : 10.1371/journal.pgen.0030160

S. Purcell, N. B. Todd-brown, K. Thomas, L. Ferreira, M. Bender et al., PLINK: a tool set for wholegenome association and population-based linkage analyses American journal of human genetics, pp.81559-575, 2007.

A. Price, N. Patterson, R. Plenge, M. Weinblatt, N. Shadick et al., Principal components analysis corrects for stratification in genome-wide association studies, Nature Genetics, vol.15, issue.8, pp.904-909, 2006.
DOI : 10.1038/ng1653

N. Patterson, A. Price, and D. Reich, Population Structure and Eigenanalysis, PLoS Genetics, vol.15, issue.12, p.190, 2006.
DOI : 1088-9051(2005)015[1576:CACSOH]2.0.CO;2

URL : http://doi.org/10.1371/journal.pgen.0020190

B. Devlin and K. Roeder, Genomic Control for Association Studies, Biometrics, vol.280, issue.4, pp.997-1004, 1999.
DOI : 10.1111/j.0006-341X.1999.00997.x

. Statacorp, Stata Statistical Software: Release 10. College Station, TX StataCorp LP, 2007.

R. Kazma, M. Babron, and E. Genin, Genetic Association and Gene-Environment Interaction: A New Method for Overcoming the Lack of Exposure Information in Controls, American Journal of Epidemiology, vol.173, issue.2, pp.225-235
DOI : 10.1093/aje/kwq352

T. Manolio, L. Brooks, and F. Collins, A HapMap harvest of insights into the genetics of common disease, Journal of Clinical Investigation, vol.118, issue.5, pp.1590-1605, 2008.
DOI : 10.1172/JCI34772

D. Reich and E. Lander, On the allelic spectrum of human disease, Trends in Genetics, vol.17, issue.9, pp.502-510, 2001.
DOI : 10.1016/S0168-9525(01)02410-6

K. Lohmueller, C. Pearce, M. Pike, E. Lander, and J. Hirschhorn, Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease, Nature Genetics, vol.33, issue.2, pp.177-182, 2003.
DOI : 10.1038/ng1071

W. Bodmer and C. Bonilla, Common and rare variants in multifactorial susceptibility to common diseases, Nature Genetics, vol.602, issue.6, pp.695-701, 2008.
DOI : 10.1186/bcr1826

T. Manolio, F. Collins, N. Cox, D. Goldstein, L. Hindorff et al., Finding the missing heritability of complex diseases, Nature, vol.41, issue.7265, pp.461747-753, 2009.
DOI : 10.1038/nature08494

I. Gorlov, O. Gorlova, S. Sunyaev, M. Spitz, and C. Amos, Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. American journal of human genetics, pp.100-112, 2008.

M. Mccarthy, Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery, Genome Medicine, vol.1, issue.7, p.66, 2009.
DOI : 10.1186/gm66

N. Fearnhead, B. Winney, and W. Bodmer, Rare Variant Hypothesis for Multifactorial Inheritance: Susceptibility to Colorectal Adenomas as a Model, Cell Cycle, vol.4, issue.4, pp.521-525, 2005.
DOI : 10.4161/cc.4.4.1591

A. Boyko, S. Williamson, A. Indap, J. Degenhardt, R. Hernandez et al., Assessing the Evolutionary Impact of Amino Acid Mutations in the Human Genome, PLoS Genetics, vol.4, issue.5, p.1000083, 2008.
DOI : 10.1371/journal.pgen.1000083.s007

G. Kryukov, L. Pennacchio, and S. Sunyaev, Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. American journal of human genetics, pp.727-739, 2007.

F. Luca, G. Bubba, M. Basile, R. Brdicka, E. Michalodimitrakis et al., Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations, PLoS ONE, vol.304, issue.507, p.3136, 2008.
DOI : 10.1371/journal.pone.0003136.s009

E. Patin, L. Barreiro, P. Sabeti, F. Austerlitz, F. Luca et al., Deciphering the Ancient and Complex Evolutionary History of Human Arylamine N-Acetyltransferase Genes, The American Journal of Human Genetics, vol.78, issue.3, pp.78423-436, 2006.
DOI : 10.1086/500614

URL : https://hal.archives-ouvertes.fr/pasteur-00169326

J. Wilson, M. Weale, A. Smith, F. Gratrix, B. Fletcher et al., Population genetic structure of variable drug response, Nature Genetics, vol.29, issue.3, pp.265-269, 2001.
DOI : 10.1038/ng761

S. Leslie, P. Donnelly, and G. Mcvean, A statistical method for predicting classical HLA alleles from SNP data American journal of human genetics, pp.48-56, 2008.

P. De-bakker, G. Mcvean, P. Sabeti, M. Miretti, T. Green et al., A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC, Nature Genetics, vol.14, issue.10, pp.381166-1172, 2006.
DOI : 10.1371/journal.pbio.0040072

G. Kazeem, C. Cox, J. Aponte, J. Messenheimer, C. Brazell et al., High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients, Pharmacogenetics and Genomics, vol.19, issue.9, pp.661-665, 2009.
DOI : 10.1097/FPC.0b013e32832c347d

W. Tassaneeyakul, T. Jantararoungtong, P. Chen, P. Lin, S. Tiamkao et al., Strong association between HLA-B*5801 and allopurinol-induced Stevens???Johnson syndrome and toxic epidermal necrolysis in a Thai population, Pharmacogenetics and Genomics, vol.19, issue.9, pp.704-709, 2009.
DOI : 10.1097/FPC.0b013e328330a3b8

J. Zhuang, K. Zondervan, F. Nyberg, C. Harbron, A. Jawaid et al., Optimizing the power of genome-wide association studies by using publicly available reference samples to expand the control group, Genetic Epidemiology, vol.316, issue.4, 2010.
DOI : 10.1002/gepi.20482

W. Guan, L. Liang, M. Boehnke, and G. Abecasis, Genotype-based matching to correct for population stratification in large-scale case-control genetic association studies, Genetic Epidemiology, vol.12, issue.6, pp.508-517, 2009.
DOI : 10.1002/gepi.20403

D. Luca, S. Ringquist, L. Klei, A. Lee, C. Gieger et al., On the use of general control samples for genome-wide association studies: genetic

. Génin, http://www.ojrd.com/content/6/1/52 matching highlights causal variants, Orphanet Journal of Rare Diseases American journal of human genetics, vol.6, issue.822, pp.52453-463, 2008.

K. Strimmer, fdrtool: a versatile R package for estimating local and tail area-based false discovery rates, Bioinformatics, vol.24, issue.12, pp.1461-1462, 2008.
DOI : 10.1093/bioinformatics/btn209

. Génin, Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.52, 2011.
DOI : 10.1093/bioinformatics/btn209